Key result
Intravenous injection of thromboxane synthetase inhibitors OKY 046 and OKY 1580 prolonged the reappearance time of cyclical reduction of coronary blood flow in dogs.
Why the study?
Does thromboxane synthetase inhibition prevent cyclical reduction of coronary blood flow in a canine model of coronary constriction?
Does thromboxane synthetase inhibition prevent cyclical reduction of coronary blood flow in a canine model of coronary constriction?
Thromboxane A2 acts as an accelerator in cyclical reduction of coronary flow induced by constriction, as its inhibition eliminates these flow reductions in a canine model.
Answers are grounded in this paper and cite their sources.
May attenuate cyclical coronary flow reductions in canine models; leaves open translation to human coronary syndromes.
Effects of new inhibitors of thromboxane synthetase, (E)-3-([1-imidazolmethyl) phenyl]-2-propenoic acid and (E)-3-[4-(pyridylmethyl) phenyl]-2-methyl-2-propenoic acid on cyclical reduction of flow in the partially constricted coronary artery were examined in anesthetized beagle dogs. Intravenous injections of both agents with a dose of 20 mg/Kg eliminated the cyclical reduction induced by constriction in the majority of experiments. However, they failed to eliminate the cyclical reduction induced by indomethacin. Indomethacin-induced reduction was eliminated by prostaglandin I2 in all experiments. It is suggested that thromboxane A2 acted as an accelerator in the cyclical reduction of coronary flow induced by coronary constriction, but did not in the reduction induced by indomethacin.
No takes yet. Share an insight, caveat, or question.
Uchida et al. (1981) studied Cyclical reduction of coronary blood flow (n=29). Thromboxane synthetase inhibitors (OKY 046 and OKY 1580) vs. Pre-injection control cycle length was evaluated on Reappearance time of cyclical reduction of coronary blood flow (min) (p=<0.01). Intravenous injection of thromboxane synthetase inhibitors OKY 046 and OKY 1580 prolonged the reappearance time of cyclical reduction of coronary blood flow in dogs.
Synapse has enriched 10 related papers. Consider them for comparative context: